100O Results of A Randomized Phase 2 Study of Pd 0332991, A Cyclin-Dependent Kinase (Cdk) 4/6 Inhibitor, In Combination with Letrozole vs Letrozole Alone For First-Line Treatment of ER + /Her2- Advanced Breast Cancer (Bc)
Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Oncology
Institutions: University of California, Los Angeles, Institut Jules Bordet, Nottingham University Hospitals NHS Trust, Cancer Trials Ireland, St. Vincent's University Hospital, Weston Park Cancer Centre, National Institute of Oncology, Antwerp University Hospital, Comprehensive Cancer Centers of Nevada, Pfizer (United States), Clatterbridge Cancer Centre NHS Foundation Trust, Norton Healthcare
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2117987173